Brazilian regulator says Bharat Biotech's Covaxin manufacturing facility fails to meet CGMP standards

Reacting to it, the city-based vaccine maker said it is working towards resolving the issues cited during the inspection and the order of 20 million doses from the Brazilian government is still active.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3sHEWjS
via IFTTT